| __timestamp | BeiGene, Ltd. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 7459000 |
| Thursday, January 1, 2015 | 58250000000 | 11831000 |
| Friday, January 1, 2016 | 98033000 | 25705000 |
| Sunday, January 1, 2017 | 269018000 | 46181000 |
| Monday, January 1, 2018 | 679005000 | 59497000 |
| Tuesday, January 1, 2019 | 927338000 | 65003000 |
| Wednesday, January 1, 2020 | 1294877000 | 74506000 |
| Friday, January 1, 2021 | 1459239000 | 126006000 |
| Saturday, January 1, 2022 | 1640508000 | 126215000 |
| Sunday, January 1, 2023 | 1778594000 | 120161000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, innovation is the lifeblood that propels companies forward. BeiGene, Ltd. and Protagonist Therapeutics, Inc. are two such companies that have consistently prioritized research and development (R&D) to stay ahead. Over the past decade, BeiGene has demonstrated a robust commitment to innovation, with R&D expenses growing by an impressive 8,000% from 2014 to 2023. In contrast, Protagonist Therapeutics has also shown a steady increase, albeit at a more modest pace, with a 1,500% rise in the same period.
This trend underscores BeiGene's aggressive strategy in pioneering new treatments, while Protagonist Therapeutics maintains a focused approach. As the biotech industry continues to expand, these companies exemplify the diverse strategies employed to harness the power of innovation. The data reveals a compelling narrative of growth and strategic investment in the future of healthcare.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
R&D Insights: How BeiGene, Ltd. and MannKind Corporation Allocate Funds
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending